Are you a journalist? Please sign up here for our press releases
Research led by Weizmann Institute scientists shows why leukemia often returns
Pools of donor immune cells could reduce the cost and expand the applications of an experimental cancer treatment.
An approach developed at the Weizmann Institute could make a cancer therapy cheaper and more effective
A gene that keeps cell division in check may hold clues to chemotherapy resistance.
A gene that protects us from cancer is also involved in the timing of a crucial stage of embryonic development.
Why do cancer cells easily give in to the temptation to divide?
A new genetic sensor kills only the malignant cancer cells in a test tube.